SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017021
Filing Date
2017-08-09
Accepted
2017-08-09 17:01:40
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20170630.htm 10-Q 1932089
2 EX-31.1 vktx-ex311_7.htm EX-31.1 20481
3 EX-31.2 vktx-ex312_6.htm EX-31.2 20552
4 EX-32.1 vktx-ex321_8.htm EX-32.1 12823
  Complete submission text file 0001564590-17-017021.txt   7947455

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vktx-20170630.xml EX-101.INS 1824119
6 XBRL TAXONOMY EXTENSION SCHEMA vktx-20170630.xsd EX-101.SCH 55001
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20170630_cal.xml EX-101.CAL 40682
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20170630_def.xml EX-101.DEF 216723
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20170630_lab.xml EX-101.LAB 396718
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20170630_pre.xml EX-101.PRE 354505
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 171018720
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences